Regeneron Pharmaceuticals CEO Boasts Recently Approved Cholesterol-Lowering Drug
July 27, 2015 at 16:55 PM EDT
Regeneron Pharmaceuticals Inc (NASDAQ: REGN)'s cholesterol-lowering drug Praluent recently received approval by the U.S. Food and ...